Before paying Omzo, the most useful question is not simply “How much is it?” It is “What exactly am I buying, from whom, and for how long?” Omzo advertises access to weight-management care, medication, delivery and ongoing support, but its public documentation separates the platform from the clinicians and pharmacy responsible for treatment. The advertised prices also lack the supply periods needed to compare them as monthly costs. Those distinctions matter before submitting an intake form, because the terms connect that step to a significant refund boundary.
This review examines Omzo’s public documentation consulted October 19, 2026, with an emphasis on questions adults in the United States can resolve before enrollment. The pages describe meaningful parts of the service, including initial and follow-up packages, prescription decisions, shipping and payment methods. They also contain conflicting statements about branded medication fulfillment, refund-request channels and mailing addresses. These gaps do not establish that care is unavailable or inadequate; they mean a prospective patient needs written clarification rather than relying on the homepage alone.
At a glance
- Who provides care
- Omzo says it is neither a medical practice nor a pharmacy. Third-party networks of U.S.-licensed clinicians assess eligibility and decide whether to prescribe.Sources: [7]
- Advertised starting prices
- The homepage advertises semaglutide starting at $179 and tirzepatide starting at $279, without defining the supply period for either price.Sources: [7]
- Package prices
- Terms describe initial GLP-1 and compounded tirzepatide packages as originally $179 and $259, respectively, with follow-up packages priced at $299 and $399. Billing intervals are unspecified.Sources: [4]
- Medication model
- Omzo says its primary program provides compounded medication prepared and shipped by a state-licensed sterile compounding pharmacy; the consulted pages do not identify that pharmacy.Sources: [7]
- Refund boundary
- Prescription orders generally become processed and nonrefundable when initial medical intake is submitted, subject to stated exceptions including medical ineligibility and certain billing errors.Sources: [4]
Who will actually be responsible for your care?
Omzo’s privacy notice identifies the business as Omzo Inc. Its homepage states that it does not employ healthcare providers, directly provide medication, or operate as a medical practice or pharmacy. Instead, clinical services come through third-party networks of U.S.-licensed clinicians. That is the provider’s description, not an independent verification of individual credentials. The consulted pages do not name the clinical networks, the clinician who would see a particular patient, or the dispensing pharmacy. Ask for those identities and their respective responsibilities before proceeding.
The privacy policy describes a handoff: Omzo collects initial qualifying information and passes it to a healthcare provider. If appropriate, that provider invites the user to schedule through a patient portal that Omzo does not operate. The healthcare provider then requests additional medical information and delivers consultation, diagnosis and treatment. Omzo’s website assessment alone does not create a doctor–patient relationship. A useful question is when you will know which clinical organization has accepted responsibility, rather than assuming the initial questionnaire itself establishes care.
Services are intended for adults 18 and older. The terms restrict products and services to the 50 U.S. states, excluding other territories and countries; that boundary does not confirm actual clinician availability in every state. The pages do not establish appointment timing, interpreter services or Spanish-language care. Readers preparing their initial inquiry can use these questions to ask before enrolling, then request state-specific availability and the expected consultation format directly from Omzo.
What do the advertised prices actually buy?
The homepage’s semaglutide and tirzepatide cards show starting prices, not documented monthly rates. Separately, the terms describe initial consultation packages using “originally priced” language and assign higher prices to follow-up packages. The table preserves those distinctions. In particular, the homepage’s tirzepatide starting price of $279 does not match the initial GLP-1 + GIP package described as originally $259. The pages do not explain whether these represent different offers, presentations or promotional periods, so neither should be substituted for the other.
Each terms-based package lists a telehealth consultation, prescription, medication, shipping and ongoing medical support if needed. The GLP-1 + GIP packages specifically identify compounded tirzepatide; the general GLP-1 package wording does not establish its precise formulation or presentation. Omzo also says medication costs are included in the fees it collects and that it pays pharmacies. These are useful inclusions, but they do not establish how much medicine comes with a payment or how long that supply is intended to last.
Before comparing Omzo with another service, request a written quote showing the exact medication, route, presentation, quantity, first charge, later charges and billing interval. Ask what “originally” means for the offer available to you. The documentation does not establish a minimum commitment or recurring payment schedule, and a package label is not proof of either. Our guide to price questions beyond a monthly headline provides a practical framework without turning these figures into unsupported monthly or annual totals.
| Offer | Published price | Important qualification |
|---|---|---|
| Homepage semaglutide | Starting at $179 | Supply period and exact formulation, route and presentation are not established. |
| Homepage tirzepatide | Starting at $279 | Relationship to the terms’ initial package price is unexplained. |
| Initial GLP-1 package | Originally priced at $179 | Includes consultation, prescription, GLP-1 medication, shipping and support if needed; supply period unspecified. |
| Follow-up GLP-1 package | $299 | Same listed service categories; billing interval unspecified. |
| Initial GLP-1 + GIP package | Originally priced at $259 | Includes compounded tirzepatide and listed services; supply period unspecified. |
| Follow-up GLP-1 + GIP package | $399 | Includes compounded tirzepatide and listed services; billing interval unspecified. |
Which medication and pharmacy would you receive?
Omzo says its primary program provides access to compounded medication prepared and shipped by a state-licensed sterile compounding pharmacy. It also says the preparations are produced in FDA-registered facilities. Registration of a facility does not mean its compounded products are FDA approved. Omzo’s terms acknowledge that compounded drugs are not FDA approved and are not reviewed by FDA for safety, efficacy or quality. They also disclaim claims that its compounded formulations are equivalent to approved drugs or will produce the same clinical outcomes.
FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence. For Omzo, the practical questions are which product a clinician proposes, why it is being considered, who prepares and dispenses it, and what the label and instructions will say. The consulted pages do not establish the concentration, exact presentation or route of every offered medicine. They also advertise custom daily oral medication kits without identifying their ingredients.
Branded prescriptions require additional clarification because Omzo’s pages conflict. The homepage says Omzo does not sell, dispense or ship branded medication, leaving patients to fill prescriptions at a chosen pharmacy and pay all associated costs. The terms instead describe limited exceptions in which Omzo manages branded dispensing and shipping, subject to clinical approval and inventory, with costs still the patient’s responsibility. Ask which pathway applies to your quoted offer. These questions about the medicine itself can help separate a product description from a broad marketing category.
What happens during evaluation and follow-up?
Omzo says eligibility depends on medical history and professional assessment, with the final prescribing decision belonging to the clinician. An advertised package that includes a prescription therefore should not be read as a guaranteed prescription. The consulted documentation does not set out provider-specific BMI criteria, required laboratory testing or a complete list of clinical restrictions. Ask what records and tests the clinician needs, whether testing carries separate charges, and what happens financially if the evaluation leads to a different treatment recommendation or no prescription.
The homepage advertises fast virtual consultations, clinician-reviewed treatment plans and ongoing support through the Omzo app. It also says plans may include prescribed medication, nutrition guidance and daily habits; “may include” does not guarantee every component in every package. Supplements are advertised for home delivery as well. Ask which elements are included in your actual plan, whether any supplements are optional purchases, and whether follow-up is scheduled routinely or initiated only when you request help. The pages do not document response-time commitments or a defined follow-up cadence.
NIDDK describes medication selection as a discussion of benefits, side effects, health conditions, other medicines, family history and costs. Follow-up concerns tolerance and response, not merely repeat payment. Applied to Omzo’s model, a useful preparation step is to ask who reviews treatment concerns, who can change a prescription, and how that clinician receives updates. Omzo’s messaging and app claims identify access channels, but they do not establish which professional answers each message or whether every concern receives a clinical visit.
What would authorize the next charge?
Omzo accepts MasterCard, Visa, American Express and Discover, conducts transactions in U.S. dollars and says it does not store payment-card details. Its terms refer to subscriptions, but the consulted pages do not establish renewal frequency, minimum commitment, the practical cancellation method or the advance notice required before another charge. Ask whether your purchase creates an automatically renewing subscription, what event triggers a follow-up payment, and whether a consultation or new clinical review is required before that payment is collected.
Cancellation and reimbursement are separate issues here. The terms say cancellation after a charge prevents future charges but does not refund previously processed charges. That provision does not explain how early you must act to prevent the next payment. Nor do the listed package prices establish whether follow-up payments occur on a calendar schedule or another basis. Obtain the actual renewal date, cancellation instructions and confirmation process in writing. These questions to settle before the next charge are particularly relevant when the public billing interval is missing.
The consulted pages do not document insurance billing, coverage support, prior authorization services or HSA/FSA acceptance. That is an information gap, not proof those options never exist. NIDDK notes that insurance coverage for weight-management medication varies by plan; coverage for a drug is also a different question from how a consultation is paid. Omzo says promotions have their own specific terms, so any advertised discount needs its own explanation of qualifying offer, initial payment and subsequent charges rather than an assumed continuing rate.
When could you get a refund?
For prescription medication, Omzo considers an order processed and generally nonrefundable once the initial medical intake is submitted, citing medical and pharmacy resources. This boundary can arise before medication is shipped, so waiting for a tracking notification is not a reliable way to preserve refund eligibility. The terms separately say supplement orders become processed and nonrefundable upon payment. Before either step, ask which product categories are in your purchase and how the published exceptions apply if your consultation or order does not proceed as expected.
There are explicit exceptions. The terms promise a full refund when the clinician determines during the initial consultation that the patient is not medically eligible. However, that exception does not apply if a disqualifying condition was knowingly omitted or misrepresented in the initial questionnaire, as evidenced by contradictions with consultation disclosures. Omzo also provides for full refunds for processing mistakes such as duplicate or incorrect charges. These are defined circumstances, not a general satisfaction guarantee or permission to recover any payment after changing your mind.
Refund requests must be made within 28 days of the original payment. The channel instructions conflict: one passage allows a written request by email or physical mail, while another rejects requests through channels other than email. The consulted text does not expose a usable email address. Resolve that contact problem before payment and retain the provider’s written instructions. The published language also does not establish when an approved refund would reach a bank account; approval or issuance should not be mistaken for a guaranteed receipt date.
Who handles delivery problems and medication questions?
Omzo’s terms say compounded medication will be shipped within the next 48 business hours after prescription approval during the telehealth consultation. That is a dispatch statement, not a promised arrival date. The homepage advertises free, discreet delivery and plain packaging, while package descriptions include shipping. Those claims describe delivery charges and presentation, not free treatment. The pages do not establish the carrier, tracking process, refrigeration arrangements or policies for replacement after loss or damage. Ask which organization handles each problem and how to reach it.
Once a product has been dispatched, the terms say shipping cannot be canceled or modified. That makes address confirmation important before fulfillment, but the pages do not specify a separate address-change deadline. Ask when an order becomes locked and whether you will receive tracking information. For an injectable GLP-1 product arriving warm or with insufficient refrigeration, FDA explicitly advises not using it and contacting the provider or dispensing pharmacy. A general customer-service message channel is not a substitute for a clear medication-specific escalation route.
FDA has also received reports of errors in measuring or administering compounded medication, including some associated with hospitalization. Those reports are not an Omzo-specific event rate. The practical question is whether you will have understandable instructions and access to the prescriber or pharmacist for clarification, rather than calculating a dose from online material. Omzo says its care team is a message away, but the consulted pages do not establish support hours, response times or which clinical professional is available through that channel.
Where should sensitive information and formal requests go?
Omzo’s privacy policy instructs users to provide health or medical information only through healthcare-provider sites after completing Omzo’s initial brief questionnaire. That distinction matters when several organizations participate in enrollment and care. Ask which portal to use for records, treatment questions and updates, and which channel is intended only for billing or administrative support. The health-data policy also contemplates use for services, advertising and marketing, and legal matters, subject to applicable law and consent where required. Readers should review those purposes rather than assuming every platform interaction has the same privacy arrangement.
Contact details need confirmation. The contact page lists 6192 Coastal Highway, Lewes, Delaware 19958, while the HIPAA policy lists 16192 Coastal Highway in the same city and ZIP code. The latter also publishes (332) 301-2274. These differing street numbers are not interchangeable for a formal mailed request. The consulted email text is masked, preventing recovery of a usable address. Ask Omzo to confirm the correct current mailing address and functioning email for billing, privacy and refund matters, rather than guessing which published version controls.
There is also unresolved role language: the HIPAA policy refers to treatment and an Omzo patient, whereas other pages describe Omzo as a platform that does not diagnose or treat. That inconsistency does not, by itself, identify who would mishandle a request. It does make a written responsibility map useful. Before submitting sensitive records or payment, obtain the clinical organization’s name, pharmacy identity, administrative contact and escalation route. Keep the quote and applicable terms together so later questions can be tied to the specific offer you accepted.
Questions & answers
Is Omzo a medical practice or the pharmacy filling my prescription?
Omzo says it is neither. Its documented model connects users with third-party clinician networks, while a pharmacy prepares and ships the primary program’s compounded medication. The consulted pages do not name those partners. Ask who will provide your consultation, hold your clinical records, issue any prescription and dispense the medication.
Can I budget $179 or $279 per month for Omzo?
Not from these pages. Those are homepage starting prices for semaglutide and tirzepatide, without established supply periods. The terms separately list initial and follow-up package prices, including a different initial tirzepatide figure described as originally $259. Request a current, itemized quote and renewal schedule before treating any amount as a monthly expense.
Does Omzo arrange branded medication?
The documentation does not give a consistent answer. The homepage says patients fill branded prescriptions at their chosen pharmacy and pay the associated costs. The terms describe limited exceptions involving Omzo-managed dispensing and shipping, subject to clinical approval and inventory. Both place branded medication costs on the patient. Confirm the applicable arrangement before paying.
Will I receive a refund if the clinician says treatment is unsuitable?
The terms provide a full refund for medical ineligibility determined during the initial consultation. They exclude that exception when a disqualifying condition was knowingly omitted or misrepresented under the stated conditions. Refund requests must be made within 28 days of payment, but the email-versus-mail instructions conflict. Confirm a usable request channel in advance.
Does the 48-business-hour shipping statement mean arrival within that time?
No. Omzo describes shipment within the next 48 business hours after prescription approval during the consultation, not delivery within that window. The consulted pages do not establish transit time or replacement arrangements. For an injectable GLP-1 delivery that arrives warm or inadequately refrigerated, FDA advises not using it and contacting the provider or dispensing pharmacy.
Does canceling Omzo return the most recent payment?
Not automatically. The terms say cancellation after a processed charge prevents future charges but does not refund that charge. Prescription orders generally become nonrefundable at initial intake submission, subject to exceptions; supplement orders do so at payment. The consulted pages do not explain the cancellation procedure or required advance notice, so obtain both before enrolling.
Our assessment
Omzo documents more than a medication advertisement: it describes a clinical handoff, bundled service categories, pharmacy fulfillment, follow-up pricing and specific refund exceptions. Those details provide a useful starting point for an enrollment conversation. However, they do not yet establish a comparable recurring cost or a fully traceable care pathway for an individual patient. The most consequential unresolved items are the actual supply and billing periods, identities of clinical and pharmacy partners, branded-medication arrangements, cancellation instructions and a usable refund contact. A practical next step is to request one written explanation covering those points before submitting intake or payment. Clear, consistent answers would make the offer easier to evaluate; unresolved contradictions should remain part of the decision rather than being filled in with assumptions.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.